Science Explorer Back to mapMap
Discussion
Researcher · Caris Life Sciences (United States) · United States

Jim P. Abraham

Jim P. Abraham publishes mostly in Oncology, Cancer Research and Pulmonary and Respiratory Medicine, on topics such as Cancer Genomics and Diagnostics, Genetic factors in colorectal cancer and Cancer Immunotherapy and Biomarkers.

ORCID 0000-0001-5038-1735 OpenAlex
World rank
#344,843
of 7,710,434 ranked researchers
Rank in United States
#123,878
of 1,627,098
Works
100
Citations
679
Citations per work
6.8
h-index
15
i10-index 19Top 36% in Oncology
Jim P. Abraham

What does Jim P. Abraham research?

Jim P. Abraham's work is mostly in Medicine (58%), Biochemistry, Genetics and Molecular Biology (19%).

Health Sciences: 58 works · 58.1% of their workMedicine: 58 works · 58.1% of their workOncology: 32 works · 32.3% of their workPulmonary and Respiratory Medicine: 12 works · 12.3% of their workPathology and Forensic Medicine: 10 works · 10.3% of their workRadiology, Nuclear Medicine and Imaging: 3 works · 3.2% of their workEverything else: 23 works · 22.6% of their workLife Sciences: 19 works · 19.3% of their workBiochemistry, Genetics and Molecular Biology: 19 works · 19.3% of their workCancer Research: 15 works · 14.8% of their workMolecular Biology: 4 works · 4.5% of their workTHEIR WORKJim P. Abraham100works
Life Sciences19%Health Sciences58%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine5858.1%
  2. Everything else2322.6%
    1. Biochemistry, Genetics and Molecular Biology1919.3%
  1. 1Oncology32% of their works
  2. 2Cancer Research15% of their works
  3. 3Pulmonary and Respiratory Medicine12% of their works
  4. 4Pathology and Forensic Medicine10% of their works
  5. 5Molecular Biology4% of their works
  6. 6Radiology, Nuclear Medicine and Imaging3% of their works

Research topics

Which keywords describe Jim P. Abraham's research?

The keywords of their largest research topics: Targeted Therapy, Cancer Genomics, Mutational Signatures, Tumor Microenvironment, Microsatellite Instability, Molecular Characterization, Immune Checkpoint Blockade and PD-1 and PD-L1.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Targeted Therapy282 topics
  2. Cancer Genomics231 topic
  3. Mutational Signatures231 topic
  4. Tumor Microenvironment192 topics
  5. Microsatellite Instability131 topic
  6. Molecular Characterization131 topic
  7. Immune Checkpoint Blockade121 topic
  8. PD-1 and PD-L1121 topic
  9. Cetuximab111 topic
  10. KRAS Mutations111 topic
  11. Cancer71 topic
  12. Ferroptosis71 topic
  13. ALK Inhibitors51 topic
  14. Cancer of Unknown Primary51 topic
  15. EGFR Mutations51 topic
  16. Metastasis51 topic
  17. Neuroendocrine Tumors41 topic
  18. Pancreatic Neuroendocrine Tumors41 topic

Where does Jim P. Abraham work?

Jim P. Abraham's main affiliation in the publication record is Caris Life Sciences (United States), United States.

How many publications and citations does Jim P. Abraham have?

OpenAlex counts 100 works and 679 citations for Jim P. Abraham, an h-index of 15, ranking #344,843 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Jim P. Abraham. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.